Actos Lawsuits Claim Drug Is Defective, Can Cause Bladder Cancer

November 6, 2013

Important Information

ClassAction.org is no longer reviewing claims for this case. The information here is for reference only. Up-to-date information and resources can be found here.

Comments |

At A Glance

This Alert Affects
Patients who were diagnosed with bladder cancer after taking any of the following diabetes drugs: Actos, ActoPlus Met, ActoPlus Met XR or Duetact.
Side Effects
Bladder cancer
Manufacturer
Takeda Pharmaceuticals
Intended Use
Actos, ActoPlus Met, ActoPlus Met XR and Duetact contain pioglitazone, an oral diabetes medication that helps control blood sugar levels and has been linked to bladder cancer.
FDA Warning
The FDA issued a warning regarding Actos and its potential link to bladder cancer on June 15, 2011.
What Can I Recover?
Medical bills, lost wages, compensation for pain and suffering
Type of Lawsuit
Mass Tort